What management recently said should help you decide what to do with this deep-discount silver stock.
Why are billionaire investors betting on stocks like Disney and GW Pharmaceuticals?
Despite several events knocking the wind out of TPI Composites' sails this year, management foresees solid growth in 2020 and beyond.
The market is miffed with the gold miner's failure to create shareholder value.
The railcar manufacturer lowered its fiscal 2019 guidance, but an acquisition should bolster growth.
Deep-value stocks like Supernus Pharmaceuticals and Party City look attractive now.
The drop in the gold miner's shares appears overdone.
Give these under-the-radar companies a closer look.
These growth companies could make a killing if their big bets pay off.
With a tough season behind it, Canadian National Railway's volumes are back to hitting record highs.
From macro headwinds to operational inefficiencies and lawsuits, the maker of Post-It Notes has a lot of things dragging on its performance.
Want to invest like the great value investor? These stocks might appeal to you.
These value stocks may not remain undervalued for long, so you might want to check them out now.
The railcar manufacturer is battling internal challenges that, if not resolved quickly, could stall its growth.
Having hit 52-week highs recently, this utility stock looks promising. But there's one big risk investors should be aware of.
Bargain hunting? These out-of-favor biotech and e-commerce stocks should appeal to value investors.
These dividend stocks offer better yields and growth potential than the beverage giant.
Surprise! This retailer and lesser-known biotechnology company could be potential multibaggers.
These two popular dividend stocks, and one you've probably never heard of, should fit a retiree's portfolio.
These dividend stocks could send you checks for a lifetime.